M. Friedlander

发表

Advanced oxidation protein products as a novel marker of oxidative stress in uremia.

P. Jungers, B. Descamps-Latscha, J. Zingraff, 1996, Kidney international.

Structure of advanced Maillard reaction products and their pathological role.

V. Monnier, M. Portero-Otín, R. Nagaraj, 1996, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Optimizing end-stage renal disease therapy for the patient with diabetes mellitus.

D. Hricik, M. Friedlander, 1997, Seminars in nephrology.

Involvement of Hydrogen Peroxide in Collagen Cross-linking by High Glucose in Vitro and in Vivo*

V. Monnier, M. Glomb, M. Friedlander, 1996, The Journal of Biological Chemistry.

Decreased production of TGF-beta 1 by human alveolar macrophages compared with blood monocytes.

B. Hamilton, Z. Toossi, C. Hirsch, 1996, Journal of immunology.

Disparate cytochemical characteristics and production of cytokines and prostaglandin E2 by human mononuclear phagocytes from the blood, lung, and peritoneal cavity.

M. Friedlander, C. Hilbert, E. Rich, 1994, The Journal of laboratory and clinical medicine.

Increased Formation of Pentosidine and Nɛ–(Carboxymethyl)lysine in End Stage Renal Disease: Role of Dialysis Clearance

V. Monnier, P. Deoreo, M. Friedlander, 2005 .

Influence of dialysis modality on plasma and tissue concentrations of pentosidine in patients with end-stage renal disease.

V. Monnier, D. Hricik, M. Friedlander, 1995, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Role of dialysis modality in responses of blood monocytes and peritoneal macrophages to endotoxin stimulation.

M. Friedlander, C. Hilbert, E. Rich, 1993, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Disparate changes in plasma and tissue pentosidine levels after kidney and kidney-pancreas transplantation.

D. Hricik, M. Friedlander, J. Schulak, 1996, Clinical transplantation.

Elevated Interleukin‐6 Levels in the Ovarian Hyperstimulation Syndrome: Ovarian Immunohistochemical Localization of Interleukin‐6 Signal

M. Friedlander, J. Goldfarb, J. Flores, 1996, Obstetrics and gynecology.

The advanced glycation endproduct pentosidine and monocyte activation in uremia.

P. Jungers, C. Verger, V. Witko-Sarsat, 1996, Clinical nephrology.

Endocrinology: Ovarian hyperstimulation syndrome: pre-ovulatory serum concentrations of interleukin-6, interleukin-1 receptor antagonist and tumour necrosis factor-α cannot predict its occurrence

M. Friedlander, J. Goldfarb, J. R. L. D. Mola, 1996 .

Ovarian hyperstimulation syndrome: pre-ovulatory serum concentrations of interleukin-6, interleukin-1 receptor antagonist and tumour necrosis factor-alpha cannot predict its occurrence.

M. Friedlander, J. Goldfarb, J. R. Loret de Mola, 1996, Human reproduction.

Elevated levels of interleukin-6 in ascites and serum from women with ovarian hyperstimulation syndrome.

M. Friedlander, J. Goldfarb, J. R. Loret de Mola, 1993, Fertility and sterility.

Gonadotropins Induce the Release of Interleukin‐1β, Interleukin‐6 and Tumor Necrosis Factor‐α from the Human Preovulatory Follicle

M. Friedlander, J. Goldfarb, J. R. L. D. Mola, 1998 .

Advanced oxidation protein products as novel mediators of inflammation and monocyte activation in chronic renal failure.

P. Jungers, J. Dayer, J. Dayer, 1998, Journal of immunology.

Gonadotropins induce higher active renin levels in the follicular fluid of normal and hyperstimulated cycles.

M. Friedlander, J. Goldfarb, B. Hecht, 1999, Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology.

Advanced Oxidation Protein Products as Novel Mediators of Inflammation and Monocyte Activation in Chronic Renal Failure1, 2

P. Jungers, J. Dayer, B. Descamps-Latscha, 1998, The Journal of Immunology.

Early and advanced glycosylation end products. Kinetics of formation and clearance in peritoneal dialysis.

V. Monnier, V M Monnier, M. Friedlander, 1996, The Journal of clinical investigation.

Abdominal Catastrophe: Visceral Injury as a Cause of Peritonitis in Patients Treated by Peritoneal Dialysis

D. Mulligan, M. Friedlander, J. Schulak, 1997, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis.

Recurrent thrombotic thrombocytopenic purpura associated with membranous glomerulopathy.

G. Jacobs, M. Friedlander, 1991, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Markedly elevated cytokines in pleural effusion during the ovarian hyperstimulation syndrome: Transudate or ascites?

M. Friedlander, J. R. Loret de Mola, F. Arredondo-Soberón, 1997, Fertility and sterility.

Elevated interleukin‐6 levels in the ovarian hyperstimulation syndrome: ovarian immunohistochemical localization of interleukin‐6 signal

M. Friedlander, J. Goldfarb, J. Flores, 1996, Obstetrics and gynecology.

Reliable determination of furosine in human serum and dialysate proteins by high-performance liquid chromatography.

V. Monnier, M. Friedlander, Y. C. Wu, 1995, Journal of chromatography. B, Biomedical applications.

Gonadotropins induce the release of interleukin-1 beta, interleukin-6 and tumor necrosis factor-alpha from the human preovulatory follicle.

M. Friedlander, J. Goldfarb, B. Hecht, 1998, American journal of reproductive immunology.